Daily feed · SEC Form 4 filings
Insider buying in low-priced stocks — Oct 25, 2018
Open-market purchases where the filing’s own weighted average price is under $5. Price comes from the Form 4 itself, not a market quote.
| Trade | Reported (ET) | Company | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 22, 2018 PForm 4 → | Oct 25, 10:22 am EDT | Cerecor Inc.CERC | ARMISTICE CAPITAL, LLC +2Director, 10% Owner | 125,800 | $4.13 | $519,064 | 17,655,800 | +0.72% | plan? late |
| Oct 25, 2018 PForm 4 → | Oct 25, 12:42 pm EDT | Anixa Biosciences IncANIX | Amit KumarChief Executive Officer, Director | 11,000 | $3.90 | $42,900 | 150,000 | +7.91% | plan? |
| Oct 22, 2018 PForm 4 → | Oct 24, 9:45 pm EDT | FITLIFE BRANDS, INC.FTLF | Judd DaytonChief Executive Officer, Director, 10% Owner | 45,895 | $0.4776 | $21,921 | 1,108,601 | +4.32% | plan? |
| Oct 25, 2018 PForm 4 → | Oct 25, 9:22 am EDT | HEMISPHERX BIOPHARMA INCHEB | Thomas K. EquelsExec. Vice Chairman/CEO/Pres., Director | 100,000 | $0.20 | $20,000 | 772,307 | +14.9% | plan? |
| Oct 24, 2018 PForm 4 → | Oct 25, 2:19 pm EDT | REGIONAL HEALTH PROPERTIES, INCRHE-A | Charles L Frischer10% Owner | 6,501 | $2.24 | $14,562 | 337,433 | +1.96% | plan? |
| Oct 22, 2018 PForm 4 → | Oct 25, 3:10 pm EDT | NYMOX PHARMACEUTICAL CORPNYMOX | James George RobinsonDirector | 8,000 | $1.67 | $13,340 | 13,340 | +150% | plan? late |
| Sep 12, 2018 PForm 4 → | Oct 25, 9:25 am EDT | CONVERSION LABS, INC.CVLB | Joseph DiTrolioDirector | 10,000 | $0.2653 | $2,653 | 82,500 | +13.8% | plan? late |
| Oct 22, 2018 PForm 4 → | Oct 24, 5:30 pm EDT | Star Gold Corp.SRGZ | David SegelovPresident, Director | 61,501 | $0.02 | $1,230 | 571,149 | +12.1% | plan? |
A trading day runs to 4:00 pm ET; filings accepted later appear on the next trading day. Rows aggregate a filing’s matching transaction lines — see the methodology for the exact roll-up rules.